Conference Coverage (Retrovirus)
HIV Infected Subjects Dampen Hopes for Chiron, Genentech Vaccines
Published in Vaccine Weekly, February 19th, 1996
Widespread publicity about the first vaccinees to become infected was a major factor in the previous cancellation of large-scale Phase III efficacy trials of the Genentech and Chiron gp120 vaccines.
Now John P. Moore of the Aaron Diamond Research Center, New York City, reports that 19 participants in Phase I/II vaccine trials developed HIV infection. Although two of the individuals received placebo vaccinations, 14 of the subjects had received a full course of three or four immunizations before becoming...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (1996-02-19)
More Articles from Vaccine Weekly
- Conference Coverage (ISVH)
HBV Vaccine Can Easily Be Combined with DPT - Conference Coverage (ISVH)
Universal HBV Vaccination Needed in Endemic Areas - Conference Coverage (Retrovirus)
AIDS Vaccine Data Called "Unpleasant, Unpalatable" - Conference Coverage (Retrovirus)
Cell Genesys Gene Therapy Safe in Early Trial - Conference Coverage (Retrovirus)
Chemokines Can Both Suppress and Activate HIV - Conference Coverage (Retrovirus)
Tiny Region of HIV Gene Missing in Long-Term Non-Progressors - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
